Biomarker research

The idea of taking a small vial of blood and being able to detect cancer at its earliest and most treatable stages is an attractive one.

A number of cancer types can be detected in pee. We speak to our scientists who are developing urine tests that aim to detect bladder and pancreatic cancer earlier.

Inflammation can prevent infections and helps repair injuries. But for people with long-term inflammatory conditions, it can sometimes lead to cancer.

Our scientists have uncovered a new marker that’s found on treatment-resistant prostate cancer cells.

Our scientists are rewriting the breast cancer rulebook. By looking at faults in tumour DNA, they’ve found that breast cancer is not 1 but 10 different diseases each with a different risk of coming back or spreading.

We’re looking into a certain type of cancer that is diagnosed once it has already spread, and doctors can’t find where the cancer first started growing.

Blood tests, breath studies and better CT scans could all help detect lung cancers earlier. We investigate the latest research that could inform lung screening.

A ’10 minute cancer test’ is big news today. But while science behind the headlines is exciting, but it’s a long way from being used to diagnose cancer.

Our researcher, Professor Caroline Dive, has received a CBE in this year’s New Year’s Honours list. We spoke to her about her outstanding career.

Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.